FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

548311000001107: Estring 2mg vaginal ring (Pfizer Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17463901000001119 Estring 2mg vaginal ring (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17464001000001116 Estring 2mg vaginal ring (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Estring 2mg vaginal ring (Pfizer Ltd) Is a Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Has active ingredient Estradiol true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Has manufactured dose form Vaginal device false Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Is a Estring true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Has dispensed dose form Vaginal device true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Has manufactured dose form Vaginal dose form true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Estring 2mg vaginal ring (Pfizer Ltd) 1 device Is pack of False Estring 2mg vaginal ring (Pfizer Ltd) Inferred relationship Existential restriction modifier
Estring 2mg vaginal ring (Pfizer Ltd) 1 device Has AMP True Estring 2mg vaginal ring (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start